A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)

Clinical trial NCT07181343 · COMPLETED

Trial details

NCT number: NCT07181343
Sponsor: Hansoh BioMedical R&D Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Psoriasis (PsO)

Start date: 2025-05-28
Primary completion: 2025-06-17
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.